SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-067544
Filing Date
2008-11-03
Accepted
2008-11-03 13:12:41
Documents
3
Period of Report
2008-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-27433_18k.htm 8-K 26833
2 EX-99.1 a08-27433_1ex99d1.htm EX-99.1 133881
3 GRAPHIC g274331mm01i001.jpg GRAPHIC 2778
  Complete submission text file 0001104659-08-067544.txt   166362
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 081156814
SIC: 2835 In Vitro & In Vivo Diagnostic Substances